- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04194606
CORonaRy Angiography and intErventions Via Distal vs Proximal aCcess (CORRECT Radial)
CORRECT RADIAL RCT: CORonaRy Angiography and intErventions Via Distal vs Proximal aCcess - a Randomized Trial of Different Radial Puncture Sites
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Cardiac catheterization is one of the most common invasive procedures worldwide. After demonstrating the superiority of the radial access over the femoral arterial approach, the radial artery puncture has become the first choice for elective and emergency coronary interventions. In addition to the often chosen access on the inside of the forearm, the course of the radial artery also allows a puncture further distal on the back of the hand. In the anatomical snuffbox, the diameter is still sufficient for the introduction of the usual sheath, however, the thrombogenic puncture at the proximal radial segment is avoided and a hemostasis by compression over the scaphoid is simplified.
This study is a prospective, open-label, randomized, multicenter study to systematically compare primary success rates and potential complications after distal transradial coronary angiography or coronary intervention versus proximal radial artery puncture over the wrist. Both puncture routes are well established in clinical routine and are used in both elective and emergency cardiac catheterization in the centers involved and worldwide. Systematic comparisons exist so far only in small series, but randomized and prospective data would be urgently needed in the frequent application. Both puncture sites are only 4-8 cm apart, so that many risks of a transradial examination (vascular injury and / or closure, perforation, spasm) are in principle common to both access sites.
The purpose of this study is to demonstrate the potential benefits of radial artery puncture in the back of the hand due to a reduced rate of chronic vascular occlusion compared to over the wrist, as well as complications (bleeding or nerve damage) and subjective tolerability ( Pain) systematically.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Karsten Schenke, MD
- Phone Number: +49401818824811
- Email: k.schenke@asklepios.com
Study Contact Backup
- Name: Gerian Grönefeld, MD
- Phone Number: +49401818824811
- Email: g.groenefeld@asklepios.com
Study Locations
-
-
-
Hamburg, Germany, 22291
- Recruiting
- Asklepios Klinik Barmbek
-
Contact:
- Karsten Schenke, MD
- Phone Number: +49401818828381
- Email: k.schenke@asklepios.com
-
Contact:
- Achim Viertel, MD
- Phone Number: +49401818826457
- Email: a.viertel@asklepios.com
-
Sub-Investigator:
- Gerian Groenefeld, MD
-
Sub-Investigator:
- Achim Viertel, MD
-
Principal Investigator:
- Karsten Schenke, MD
-
-
Bavaria
-
Erding, Bavaria, Germany, 85435
- Not yet recruiting
- Klinikum Landkreis Erding
-
Contact:
- Nader Joghetaei, MD
- Phone Number: +49 8122 59-1760
- Email: nader.joghetaei@klinikum-erding.de
-
Principal Investigator:
- Nader Joghetaei, MD
-
-
NRW
-
Düsseldorf, NRW, Germany, 40953
- Not yet recruiting
- Sana Kliniken Düsseldorf GmbH
-
Contact:
- Rostyslav Prog, MD
- Phone Number: +49 211 997 24656
- Email: rostyslav.prog@sana.de
-
Principal Investigator:
- Rostyslav Prog, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Written consent to participate in the study
- Age ≥ 18 years
- Indication for coronary angiography or coronary intervention
- Palpable pulse of the proximal and distal radial artery on one or both arms
Exclusion Criteria:
- Hemodynamic instability (according to the criteria of cardiogenic shock: Hf> 120 / min and RR syst <90 mmHg)
- Intubated patients
- Sonographic evidence of occlusion of both radial arteries
- Pregnant or lactating women
- Patients that are currently or have within the last 30 days participated in a clinical trial
- Primarily planned bilateral radial access; e.g. in the context of a CTO recanalization
- Patients who are in a dependency / employment/ relationship with the study doctor or center
- Patients with bilateral hand or arm misalignment / paresis that makes a radial Access impossible
- Patients who do not speak German or who are unable to understand the nature, significance or scope of the study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Forearm radial access
Patients who undergo coronary angiography or intervention by forearm radial artery access
|
After puncture of the radial artery in either the area of the anatomical snuffbox or the lower forearm following modified Seldinger technique a sheath will be advanced and a CAG or PCI will be performed.
After the procedure is finished the sheath will be withdrawn and a standard closure device will be applied to achieve hemostasis.
The choice of the patients side, the sheath, the catheters and the closing device will be at the discretion of the interventionalist.
|
Experimental: Distal radial access
Patients who undergo coronary angiography or intervention by accessing the distal radial artery in the area of the anatomical snuff-box
|
After puncture of the radial artery in either the area of the anatomical snuffbox or the lower forearm following modified Seldinger technique a sheath will be advanced and a CAG or PCI will be performed.
After the procedure is finished the sheath will be withdrawn and a standard closure device will be applied to achieve hemostasis.
The choice of the patients side, the sheath, the catheters and the closing device will be at the discretion of the interventionalist.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Lower rate of forearm radial artery occlusion (RAO)
Time Frame: 30 days
|
Use of color doppler ultrasound to assess the patency of the radial artery used in the index procedure.
|
30 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Puncture success rate of the randomized puncture site
Time Frame: During the procedure
|
Comparison of the rate of successful Insertion of the sheath in each group
|
During the procedure
|
Access cross over rate
Time Frame: During the procedure
|
Comparison of the rate of access site cross over in each group to complete the planned procedure
|
During the procedure
|
Duration of puncture
Time Frame: During the procedure
|
Exact measurement of the duration of the puncture in seconds
|
During the procedure
|
Hematoma, bleeding and other complications
Time Frame: 48 hours
|
Registration of complications associated with the procedure, hematoma size, bleeding according to the BARC Score
|
48 hours
|
Use of standard questionaire to assess pain
Time Frame: 30 days
|
Visual analog scale is used to assess pain
|
30 days
|
Incidence of vasospasm
Time Frame: during the procedure
|
The incidence of vasospasm that necessitates additional medication or Forces Access site cross over is registered
|
during the procedure
|
Use of standard questionaire to assess Hand function
Time Frame: 30 days
|
QuickDASH questionaire is used to assess Hand function
|
30 days
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Karsten Schenke, MD, Asklepios Klinik Bambek Hamburg
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CORRECT Radial RCT 2019
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Coronary Artery Disease
-
Elixir Medical CorporationIstituto Clinico HumanitasActive, not recruitingCoronary Artery Disease | Chronic Total Occlusion of Coronary Artery | Multi Vessel Coronary Artery Disease | Bifurcation of Coronary Artery | Long Lesions Coronary Artery DiseaseItaly
-
Fundación EPICActive, not recruitingCoronary Artery Disease | Left Main Coronary Artery Disease | Left Main Coronary Artery Stenosis | Restenosis, CoronarySpain
-
Peking Union Medical College HospitalRecruitingCoronary Artery Disease | Inflammation | Coronary Artery Disease Progression | Coronary Artery Stenosis | Coronary Artery Restenosis | Inflammatory Disease | Inflammation VascularChina
-
Peking Union Medical College HospitalNot yet recruitingCoronary Artery Disease | Inflammation | Coronary Artery Disease Progression | Coronary Artery Stenosis | Coronary Artery Restenosis | Inflammatory Disease | Inflammation VascularChina
-
IGLESIAS Juan FernandoUniversity of BernNot yet recruiting
-
National Institutes of Health Clinical Center (CC)National Heart, Lung, and Blood Institute (NHLBI)CompletedCoronary Arteriosclerosis | Coronary Artery Disease (CAD) | Obstructive Coronary Artery DiseaseUnited States
-
Barts & The London NHS TrustImperial College London; Brunel UniversityNot yet recruitingCORONARY ARTERY DISEASE
-
Abbott Medical DevicesCompletedCoronary Artery Disease | Coronary Disease | Coronary Occlusion | Chronic Total Occlusion of Coronary Artery | Coronary Restenosis | Coronary Artery Stenosis | Coronary Artery RestenosisBelgium
-
Fundación EPICRecruitingCoronary Artery Disease | Coronary Disease | Coronary Occlusion | Left Main Coronary Artery Disease | Coronary Artery StenosisSpain
-
San Luigi Gonzaga HospitalRecruitingCoronary Disease | STEMI | Coronary Artery Ectasia | Right Coronary Artery Occlusion | Right Coronary Artery StenosisSpain, Italy
Clinical Trials on Use of radial artery for access for a coronary angiography or intervention
-
North Texas Veterans Healthcare SystemCompletedVascular Access ComplicationUnited States
-
Yonsei UniversityMyung In PharmRecruitingRadiation ExposureKorea, Republic of
-
Sidekick HealthLandspitali University HospitalRecruiting
-
Azienda USL ModenaCompleted
-
Abbott Medical DevicesRecruitingHeart Failure | Left Bundle-Branch BlockUnited States
-
Federico II UniversityAdvicePharma GroupActive, not recruitingMyocardial Infarction | Coronary Artery Disease | Acute Coronary Syndrome | Chronic Coronary SyndromeItaly
-
Centre Henri BecquerelUnknownTolerance of PICC Line Versus Implanted Port for Adjuvant Chemotherapy in Early Breast Cancer (EPIC)Early Stage Breast CarcinomaFrance
-
HIV Prevention Trials NetworkNational Institute on Drug Abuse (NIDA); National Institute of Allergy and...Enrolling by invitationHIV Infections | Opioid Use | Drug Use | Opioid-use DisorderUnited States
-
Kartal Kosuyolu Yuksek Ihtisas Education and Research...CompletedSurgery | Hepatic Impairment | Cardiac Disease | Hyperbilirubinemia
-
Alexandria UniversityActive, not recruitingADHD | Executive Dysfunction | Impulsive AggressionEgypt